Biolab Farmacêutica creates AI that automates the analysis of pharmaceutical leaflets

From operational to strategic, the new tool turns time into value

The artificial intelligence developed by Biolab Farmacêutica to automate the comparison between the package leaflets of similar drugs and their respective reference drugs marks an unprecedented advance for the pharmaceutical sector. By transforming a traditionally manual process into an automated, precise task in line with Anvisa's requirements, the exclusive technology has already been registered with the National Institute of Industrial Property (INPI) and is therefore legally protected until 2075.

The tool was developed with the participation of the IT and Regulatory teams, with the aim of solving a challenge: the process of comparing a single package leaflet involved two people over 20 working days, which equated to 32 hours of work. After many studies, the new solution accomplishes the same task with just one person, in around 2 hours - a time saving of more than 90%.

"This technology has eliminated an entirely operational bottleneck, susceptible to human error. The time savings, combined with the accuracy of the data, made us decide to register it. In addition, its use frees up professionals for more strategic activities, in line with Biolab's objectives," says Denise Queiroz, the company's Regulatory Affairs director.

The AI combines the processing of the Gemini Flex engine with an agent programmed in Python, responsible for organizing and applying the prompts that carry out the analysis. The interface, built with Streamlit, is simple and intuitive: the user uploads two leaflets and, in a few minutes, the tool returns a table with all the points compared and any differences highlighted. The result can be exported as a PDF, facilitating documentation and internal processes.

"We developed an AI trained to focus specifically on regulatory items, such as composition, dosage and adverse effects. The technology also accepts specific questions, such as identifying the presence of terms like 'drowsiness' or 'overdose' in the compared texts," adds Manuela Marques, Supply Chain and IT director.

Check out the full article: https://revistadafarmacia.com.br/industria/biolab-farmaceutica-cria-ia-que-automatiza-analise-de-bulas/